| Rhumatismes inflammatoires : où en est-on avec les JAK-inhibiteurs ? | Rheuma Plus / Schweiz |  | | 2025 | 20 | 136 |
|
| Identification of individuals at high risk of developing rheumatoid arthritis : a balanced random forest model in a cohort of 1544 first-degree relatives | RMD open | | | 2025 | 28 | 85 |
|
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open | | | 2024 | 117 | 102 |
|
| Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA | BMJ open | | | 2024 | 145 | 141 |
|
| Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome | JHEP reports | | | 2024 | 175 | 285 |
|
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | | 2023 | 76 | 119 |
|
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | | 2023 | 100 | 287 |
|
| Gut microbiome in the development of rheumatoid arthritis | | | | 2023 | 436 | 607 |
|
| Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases | Frontiers in cellular and infection microbiology | | | 2023 | 122 | 214 |
|
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | | 2023 | 202 | 385 |
|
| Periodontitis in first degree-relatives of individuals with rheumatoid arthritis: a short narrative review | Frontiers in oral health | | | 2022 | 212 | 144 |
|
| Peut-on prédire la polyarthrite rhumatoïde ? | Revue du rhumatisme monographies |  | | 2022 | 126 | 0 |
|
| Global epidemiology of rheumatoid arthritis | Nature reviews. Rheumatology | | | 2022 | 405 | 1 |
|
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | | 2021 | 365 | 251 |
|
| Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis | Rheumatology | | | 2021 | 270 | 0 |
|
| Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab | RMD open | | | 2021 | 273 | 140 |
|
| Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study | The Lancet. Rheumatology | | | 2020 | 254 | 322 |
|
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | | 2020 | 248 | 240 |
|
| Mini-Review: Human Microbiome and Rheumatic Diseases | Frontiers in cellular and infection microbiology | | | 2020 | 202 | 264 |
|
| The role of nutritional factors and intestinal microbiota in rheumatoid arthritis development | Nutrients | | | 2020 | 179 | 230 |
|
| Transplantation de microbiote fécal : état actuel et perspectives | Revue médicale suisse | | | 2019 | 335 | 4 |
|
| Intestinal dysbiosis in RA development: difficulty of establishing causality. Response to: 'Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study' by Inamo | Annals of the Rheumatic Diseases | | | 2019 | 350 | 4 |
|
